$SBRA

Sabra Health Care REIT (SBRA) Stock Holds Steady As Loan Losses Cloud Cash Gains

Sabra Health Care REIT (SBRA) shares rose about 0.2% to around $20.66 after Q2 2026 results. Revenue increased to $238.09 million from $189.98 million, but net income fell to a $25.20 million loss from a $65.54 million profit. Normalized FFO was $0.38 and adjusted FFO $0.40, supporting a $0.30 dividend. The company recorded a $102.4 million loan loss provision.

Original reporting
Published Aug 5, 2026, 2:12 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Sabra Health Care REIT (SBRA) Stock Holds Steady As Loan Losses Cloud Cash Gains — source image
Decision brief

The 30-second read

$SBRANeutralMed
01

Why it matters

For traders, the key tension is stable normalized cash generation and dividend coverage versus a large loan-loss provision and execution risk tied to Avamere operator transition.

02

Market read

SBRA’s earnings read-through suggests limited immediate shock to cash coverage, but credit provisioning and near-term execution risk remain the swing factors.

03

What to watch

The article does not quantify occupancy, rent collection trends, or the timing of the RCA mortgage resolution, which could materially change forward credit expectations.

Relevance 6/10Novelty 5/10Timing: post-earnings, early August 5 read-through

Background

The piece frames SBRA’s Q2 2026 performance around cash NOI, normalized AFFO coverage, and credit-related loan loss reserves.

Company-level read

Ticker impact

$SBRANeutralMedium confidence
Context

SBRA reported Q2 results with normalized AFFO of $0.40 covering a $0.30 dividend, while booking a $102.4M loan-loss provision.

Expected impact

Near-term trading likely stays range-bound unless management updates on loan resolution and Avamere execution; downside risk persists from credit provisions.

Evidence & confidence

The article cites stable share performance (+0.2%) alongside higher cash NOI and dividend coverage, but also highlights a sizable loan-loss reserve and expected operator change in the second half.

Market effects

Highlights how senior housing REITs can show stable normalized cash metrics while still taking large credit-related provisions.

No specific regional impact described beyond US and Canada operations.

Limited, as the disclosure is company-specific within US healthcare REITs.

Counterpoint

The normalized AFFO coverage and higher cash NOI may be more durable than the headline net loss suggests, implying the loan-loss provision could be a one-time overhang.

Key entities

  • Sabra Health Care REIT

    US-listed healthcare REIT reporting Q2 2026 cash-flow metrics, dividend coverage, and a large loan-loss provision.

  • Avamere

    SBRA portfolio referenced for transition risk and expected operator change in the second half.

  • RCA mortgage resolution

    Referenced as the basis for loan loss provisions and reserves excluded from normalized metrics.

Related articles

$SBRAMed

Sabra Health Care REIT, Inc. (SBRA): Results of Operations and Financial Condition

Sabra Health Care REIT, Inc. (SBRA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.3 4 sbraex9932026q2.htm Q2 2026 NON-GAAP RECONCILIATIONS Document Reconciliations of Non-GAAP Financial Measures June 30, 2026 (Unaudited) SABRA HEALTH CARE REIT, INC. RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES 2026 OUTLOOK FFO, Normalized FFO, AFFO and Normalized AFFO

$SBRAMedAI 8/10

Why Sabra Health Care REIT Stock Soared Today

Sabra Health Care REIT (SBRA) shares rose over 10% after the company issued an operational update. Sabra said it signed letters of intent to retenant 26 Avamere properties, targeting $53M annual rent versus $41M prior. It also arranged to retire a $300M RCA mortgage with $200M cash. Sabra raised 2026 guidance to $0.37-$0.39 headline net income and $1.59-$1.61 normalized AFFO.

$CATMedAI 8/10

Critical Minerals: How Data Centres are Boosting Caterpillar

Caterpillar shares rose about 12% on 4 August after its Q2 results beat analyst expectations. The company reported revenue of $20.54bn, up 24% year on year, and adjusted EPS of $8.17 versus $6.20 expected. Operating profit was $4.3bn. Order backlog reached $72.1bn, up 92%, supporting construction and power demand tied to data centres.

$LEEMed

Lee Enterprises, Incorporated Q3 2026 Earnings Call Summary

Lee Enterprises reported Q3 2026 progress toward a digital-first model, saying digital revenue was 57% of total revenue. It cited a 15% cash cost reduction and fifth straight quarter of comparable adjusted EBITDA growth, raising full-year adjusted EBITDA guidance to 22% to 28%. The company expects about $18M annual interest savings, positive net income of $5.2M, and plans debt paydown using excess cash and non-core asset sales.

$LNGMed

Cheniere Energy, Inc. Q2 2026 Earnings Call Summary

Cheniere Energy’s Q2 2026 call cited production outperformance and faster Corpus Christi Stage 3 startup for a second guidance raise. Full-year 2026 adjusted EBITDA guidance was revised to $7.9B-$8.4B. Management expects Sabine Pass Phase 1 FID by early 2027, targets dividend growth of at least 10% annually, and issued $1.75B dual-tranche bonds extending maturities to 2056.

$MARAMed

Marathon Digital Holdings, Inc. Q2 2026 Earnings Call Summary

Marathon Digital Holdings (MARA) discussed its Q2 2026 shift from Bitcoin mining to power-centric AI infrastructure. Management said it aims to expand energized power capacity to 4.8 GW via Matagorda and the pending Long Ridge deal, projected to add about $144 million annualized EBITDA. MARA reported a $611 million net loss, including a $343 million unrealized fair value adjustment tied to a 28% lower Bitcoin average price.